Treatment of HCV with DAAs in cirrhosis: Risk of early de novo hepatocellular carcinoma (HCC) and impact of HCC on SVR.

被引：0
|
作者：
Sterling, Richard K. [1 ]
Patel, Vaishali [1 ]
Kumral, Dennis [1 ]
Lewis, Shawn [1 ]
Cherian, Reena [1 ]
Driscol, Carolyn [1 ]
Genther, Kathleen [1 ]
Lee, Hannah [1 ]
Matherly, Scott [1 ]
Stravitz, R. Todd [1 ]
Siddiqui, Mohammad S. [1 ]
Luketic, Velimir A. [1 ]
Puri, Puneet [1 ]
Sanyal, Arun J. [1 ]
机构：
[1] Virginia Commonwealth Univ, Richmond, VA USA
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1591
引用
收藏
页码：851A / 851A
页数：1
相关论文
共 50 条
  • [1] Early occurrence of hepatocellular carcinoma (HCC) in patients with HCV cirrhosis treated with direct-acting antivirals (DAAs)
    Calvaruso, V.
    Cabibbo, G.
    Cacciola, I.
    Petta, S.
    Madonia, S.
    Bellia, A.
    Tine, F.
    Distefano, M.
    Giannitrapani, L.
    Prestileo, T.
    Mazzola, G.
    Davi, A.
    Larocca, L.
    Ardiri, A.
    Digiacomo, A.
    Gussio, M.
    Guarneri, L.
    Magro, A.
    Averna, A.
    Iacobello, C.
    Scalisi, I.
    Cartabellotta, F.
    Savalli, F.
    Russello, M.
    Scifo, G.
    Squadrito, G.
    Camma, C.
    Raimondo, G.
    Craxi, A.
    Di Marco, V.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E60 - E60
  • [2] Interferon (IFN), HCV child a cirrhosis and hepatocellular carcinoma (HCC).
    Testino, G
    Andorno, E
    Mondello, R
    Ansaldi, F
    Icardi, G
    Valentini, M
    GASTROENTEROLOGY, 2000, 118 (04) : A1494 - A1494
  • [3] Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs)
    Cabibbo, G.
    Cacciola, I.
    Cannavo, M. R.
    Madonia, S.
    Calvaruso, V.
    Petta, S.
    Distefano, M.
    Larocca, L.
    Prestileo, T.
    Tine, F.
    Digiacomo, A.
    Bertino, G.
    Giannitrapani, L.
    Benanti, F.
    Davi, A.
    Volpes, R.
    Scalisi, I.
    Iacobello, C.
    Mazzola, G.
    Cartabellotta, F.
    Guarneri, L.
    Portelli, V.
    Averna, A.
    Russello, M.
    Scifo, G.
    Squadrito, G.
    Raimondo, G.
    Craxi, A.
    Di Marco, V.
    Camma, C.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E59 - E59
  • [4] Risk of early de-novo hepatocellular carcinoma (HCC) in patients with genotype-1b HCV compensated cirrhosis treated with 3 direct-acting antivirals (DAAs) - a real life, multicenter study
    Muzica, C. -M.
    Stanciu, C.
    Stoica, O.
    Girleanu, I.
    Huiban, L.
    Alexandru, C.
    Cuciureanu, T.
    Singeap, A. -M.
    Chiriac, S.
    Trifan, A.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S424 - S425
  • [5] The risk of hepatocellular carcinoma (HCC) in patients with HCV cirrhosis is predicted by a polymorphism of MERTK gene
    Calvaruso, Vincenza
    Grimaudo, Stefania
    Pipitone, Rosaria Maria
    Bavetta, Maria Grazia
    Cabibbo, Giuseppe
    Conte, Elisabetta
    Bronte, Fabrizio
    Craxi, Antonio
    Di Marco, Vito
    HEPATOLOGY, 2014, 60 : 833A - 833A
  • [6] Factors implicated in the risk of developing hepatocellular carcinoma (HCC) in patients with cirrhosis due to HCV. Implications of Sustained Virological Response (SVR)
    Castano, A.
    Gomez, A.
    Torner, M.
    Fraile, M.
    Alvarez-Navascues, C.
    Cadahia-Rodrigo, V.
    Dieguez, M. L. G.
    Varela, M.
    Rodriguez, M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S431 - S432
  • [7] The risk of cirrhosis and hepatocellular carcinoma (HCC) among HCV-Infected patients: A systematic review
    El-Serag, HB
    Goodgame, B
    Shaheen, N
    GASTROENTEROLOGY, 2002, 123 (01) : 50 - 50
  • [8] Familial risk of liver cirrhosis (LC) find hepatocellular carcinoma (HCC) among HCV patients
    Palumbo, VA
    Pasta, L
    Pietrosi, G
    Albanese, M
    Licata, A
    D'amico, G
    Pagliaro, L
    JOURNAL OF HEPATOLOGY, 2001, 34 : 99 - 99
  • [9] STEATOHEPATITIC-HEPATOCELLULAR CARCINOMA (SH-HCC) A DISTINCTIVE TYPE OF HCC IN HCV-CIRRHOSIS (HCV-C)
    Salomao, Marcela
    Yu, Woojin M.
    Brown, Robert S.
    Emond, Jean C.
    Lefkowitch, Jay H.
    HEPATOLOGY, 2009, 50 (04) : 1113A - 1113A
  • [10] Different Radiological Findings between Hepatocellular Carcinoma (HCC) after HCV Eradication with Direct Acting Antivirals (DAAs) and HCV-RNA Positive HCC
    Shimizu, Takao
    Tsuchiya, Kaoru
    Takada, Hitomi
    Tamaki, Nobuharu
    Yasui, Yutaka
    Nakanishi, Hiroyuki
    Itakura, Jun
    Takahashi, Yuka
    Kurosaki, Masayuki
    Izumi, Namiki
    HEPATOLOGY, 2018, 68 : 508A - 509A
12345